BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
BTX.WS was delisted on the 26th of September, 2018.
7 hedge funds and large institutions have $0 invested in BioTime Inc Warrants (Expiring October 1, 2018) in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 33 closing their positions.
83% less funds holding
Funds holding: 40 → 7 (-33)
100% less capital invested
Capital invested by funds: $31K → $0 (-$31K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 33
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$20K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$2K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$1K |
BTX.WS Hedge Fund Activity: Q3 2018 in Review
7 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) for Q3 2018, worth a combined $0 — down 100% from $31K a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of BTX.WS and 0 opened new positions — a net loss of 33 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Ionic Capital Management, exiting entirely with an estimated $20K sold.
- 7 institutional investors held BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) as of Q3 2018, down from 40 in Q2 2018.
- Funds reported $0 of BioTime Inc Warrants (Expiring October 1, 2018) stock for Q3 2018, down 100% quarter-over-quarter.
- 0 funds opened new BioTime Inc Warrants (Expiring October 1, 2018) positions in Q3 2018 and 33 closed out, a net change of -33 holders.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) seller in Q3 2018 was Ionic Capital Management, an estimated $20K sold.
Based on aggregated 13F filings for Q3 2018.